A peer-reviewed journal would not survive without the generous time and insightful comments of the reviewers, whose efforts often go unrecognized. Although final decisions are always editorial, they are greatly facilitated by the deeper technical knowledge, scientific insights, and passion that reviewers bring to our deliberations. For these reasons, the Editors of Cancer Imaging would like to thank all of our 2024 reviewers, with particular thanks due to the following dedicated 2024 reviewers:
Chen Gao, Zhejiang Chinese Medical University | Sungmin Woo, NYU Grossman School of Medicine | Yuki Arita, Memorial Sloan Kettering Cancer Center | Ibrahim Hadadi, King Khalid University | Nicolò Gennaro, Northwestern University | Harriet Lancaster, iDNA | Conrad-Amadeus Voltin, University of Cologne | Kazufumi Ohmura, Gifu University Graduate School of Medicine | Khanyisile N. Hlongwa, University of Cape Town | Wei Jiang, Fujian Medical University Union Hospital | Qing Zhong, Fujian Medical University Union Hospital | Hongyi Liu, Johns Hopkins University | Stephane Chauvie, Santa Croce e Carle Hospital | Shivakumar Swamy Shivalingappa, Health Care Global Hospital | Katrin S. Roth, University Hospital Cologne | Feiyang Zhong, Nankai University | Ren-Hao Chan, National Cheng Kung University | Xiaolong Gu, Hebei Medical University | Vandana K. Dhingra, All India Institute of Medical Sciences, Rishikesh | Kui Sun, Shandong First Medical University | Jee Seok Yoon, Korea University
2024 reviewer acknowledgments
Aims and scope
Cancer Imaging is an open access, peer-reviewed journal publishing original articles, reviews and editorials written by expert international radiologists working in oncology.
The journal encompasses CT, MR, PET, ultrasound, radionuclide and multimodal imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.
Please click here for more information.
Discounts and waivers on APCs
Authors may be eligible for a discounted or waived article processing charges (APCs) in Cancer Imaging if their institution is a participant in one of Springer Nature’s fully open access agreements. Fees are routinely waived for authors from low-income countries. For other countries, APC waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process.
Discount for ICIS members
If you are a member of the International Cancer Imaging Society (ICIS), you will receive a 20% discount for publishing in Cancer Imaging. Please email the Journal Editor for details.
Articles
-
-
Hierarchical diagnosis of breast phyllodes tumors enabled by deep learning of ultrasound images: a retrospective multi-center study
-
The impact of a simple positioning aid device on the diagnostic performance of thyroid cancer in CT scans: a randomized controlled trial
-
Preoperative prediction of WHO/ISUP grade of ccRCC using intratumoral and peritumoral habitat imaging: multicenter study
-
Enhancing 18F-FDG PET image quality and lesion diagnostic performance across different body mass index using the deep progressive learning reconstruction algorithm
-
How We Read Oncologic FDG PET/CT
-
Prostate MRI based on PI-RADS version 2: how we review and report
-
Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
-
MRI of endometrium cancer – how we do it
-
Cross-sectional imaging in cancers of the head and neck: how we review and report
What is trending?
Click here to see which articles published in Cancer Imaging have been shared the most in the past three months.
ICIS 2025: 24th Annual Teaching Course
Registration now open! For more meeting information, abstract submission guidelines and to register for early bird rates please click HERE (early bird ends 31 May 2025; abstract submission deadline 30 May 2025).
Past and upcoming ICIS events
ICIS SGCR WIRES 2024 On-Demand
Watch recordings from the ICIS SGCR WIRES 2024 conference held in Singapore. Available to purchase are 1, 2 or 3 days of content.
For more information or to purchase, please click HERE.
ICIS Read with the Experts: Hepatobiliary Series
Segment 1: Thursday 22 May 2025
Online
Click HERE for further details & to register.
ICISi Masterclass in Rectal Cancer MRI
Thursday 16 & Friday 17 October 2025 (2 half days)
Online
Click HERE for further details & to register.
ICISi Masterclass in Head & Neck Cancer Imaging
Thursday 6 & Friday 7 November 2025 (2 half days)
Online
Click HERE for further details & to register.
Winner of the 2024 Reznek Prize
We are delighted to announce that the winner of the 2024 Reznek Prize, awarded by ICIS, is the article "MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins" by Dr. Dong He et al. Published in 2021, the paper has received 36 citations so far. Congratulations to Dr. He and all co-authors!
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: None
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
Official journal of
-
Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.5
5-year Journal Impact Factor: 4.3
Source Normalized Impact per Paper (SNIP): 1.416
SCImago Journal Rank (SJR): 1.227Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 157Usage 2024
Downloads: 976,377
Altmetric mentions: 193